ADXS Insider Trading Activity and SEC Form 4 Filings
ADXS insider trading summary
No open-market insider purchases or sales of Ayala Pharmaceuticals, Inc. (ADXS) have been reported on SEC Form 4 in the past 12 months.
Latest ADXS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 18, 2023 | Israel Biotech Fund I, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | I.B.F. Management Ltd. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund I, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund GP Partners II, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund II, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund GP Partners II, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | I.B.F. Management Ltd. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
| Oct 18, 2023 | Israel Biotech Fund II, L.P. | 10% Owner | Buy | $0 (658,858 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.